TS
ABBV icon

Triglav Skladi’s AbbVie ABBV Stock Holding History

Triglav Skladi’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
47,600
+24,000
+102% +$5.16M 0.63% 33
2026
Q1 		$5.13M Sell
23,600
-29,452
-56% -$6.53M 0.36% 54
2025
Q4 		$12.1M Sell
53,052
-3,369
-6% -$767K 0.77% 29
2025
Q3 		$13.1M Buy
56,421
+28,700
+104% +$5.84M 0.85% 27
2025
Q2 		$5.15M Sell
27,721
-17,400
-39% -$3.23M 0.37% 54
2025
Q1 		$9.45M Buy
45,121
+7,400
+20% +$1.44M 0.79% 31
2024
Q4 		$6.7M Buy
+37,721
New +$6.94M 0.53% 46

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Triglav Skladi's ABBV Position: Q2 2026 in Review

Triglav Skladi increased its AbbVie (ABBV) stake by 102% in Q2 2026, buying an estimated $5.16M and bringing the position to 47,600 shares worth $12M. The position accounts for 0.63% of the portfolio, ranked #33.

Triglav Skladi first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.1M in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Triglav Skladi held 47,600 shares of AbbVie worth $12M as of Q2 2026.
  • Triglav Skladi bought 24,000 AbbVie shares in Q2 2026, an estimated $5.16M.
  • AbbVie made up 0.63% of Triglav Skladi's portfolio in Q2 2026, its #33 holding.
  • Triglav Skladi first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's AbbVie position peaked at $13.1M in Q3 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.